Dr. Holger B. Müller, CFA

Dr. Holger B. Müller, CFA

Project Manager

Followers of Dr. Holger B. Müller, CFA6000 followers
location of Dr. Holger B. Müller, CFAKüsnacht, Zurich, Switzerland

Connect with Dr. Holger B. Müller, CFA to Send Message

Connect

Connect with Dr. Holger B. Müller, CFA to Send Message

Connect
  • Timeline

  • About me

    Commercializing innovations in scientifically driven industries as CEO, independent advisor, interim manager, and non-executive director

  • Education

    • CFA Institute

      2004 - 2007
      CFA Financial Services https://credentials.cfainstitute.org/0ee1cd94-9687-4757-8cf8-b2e22a4432b7
    • ETH Zürich

      1994 - 1999
      PhD Chemistry PhD
    • Leibniz Universität Hannover

      1989 - 1994
      Master of Science - MS Chemistry Master of Science
    • MIT Sloan School of Management

      2024 - 2024
      Executive Education Artificial Intelligence: Implications for Business Strategy
  • Experience

    • Bain & company

      Aug 1999 - Mar 2004
      Project Manager
    • Novartis

      Mar 2004 - Aug 2013

      Cross franchise vigilance of branded Rx portfolio for generic competition Commercial lead (marketing & sales) for specialty medicines franche in France and Benelux Commercial lead of mass market Ph II/III development program in the respiratory therapeutic area. Commercial strategy development, including product prositioning Portfolio management of >15 early stage (pre-clinical to Ph II) development projects across 4 therapeutic areas. Identification of in-licensing and acquisition out-of-strategy growth options. Lead of commercial Due Diligences of in-licensing targets

      • Global Head of Brand Vigilance

        Jul 2011 - Aug 2013
      • General Manager Rare Genetic Disease Franchise

        Nov 2009 - Jun 2011
      • Strategic Marketing Director Respiratory

        Jan 2008 - Nov 2009
      • Disease Area Strategy Director

        Jan 2007 - Dec 2007
      • Director General Medicines

        Mar 2006 - Dec 2006
      • Senior Strategic Planner

        Mar 2004 - Mar 2006
    • Athenex

      Sept 2013 - Aug 2017
      SVP Commercial Operations

      Responsible for commercializing the lead product Cytovir CMV in Europe and positioning the pipeline oncology drug CMD-003 globally.

    • Biognosys AG

      Feb 2018 - Feb 2019
      Chief Commercial Officer
    • Liom

      Mar 2019 - Apr 2019
      Chief Operating Officer

      Day-to-day management of the operations of a Medical Device Start-Up

    • Health Advances

      Dec 2019 - Jan 2023
      Vice President & Head of Europe

      Consultative Selling & Office Leadership

    • Crearene AG

      Apr 2022 - now
      Non Executive Director

      Providing strategic advise and company oversight

    • Tmmune AG

      Feb 2023 - now
      Managing Director

      Tmmune is a boutique consultancy for life sciences companies providing strategic direction and interim management.

    • Disruptive Pharma AB

      Mar 2023 - Dec 2023
      Business Development Director
    • ProVascTec

      Mar 2023 - now
      Chief Executive Officer & Co-Founder

      ProVascTec’s mission is to positively impact the lives of patients suffering from cardiovascular complications

  • Licenses & Certifications

    • 5-years professional learning

      CFA Institute
      Nov 2025
    • Speaker at Why Summits

      Why Summits
      Mar 2019
    • CFA Institute Charterholder

      CFA Institute
      Aug 2008
      View certificate certificate